Use of New Generation Fetoscopes in Pregnancies Affected by Fetal Diseases Amenable to Fetoscopy Therapy

Overview

About this study

The purpose of this study is to determine feasibility and safety of performing in utero surgery with the Karl Storz fetoscopes (11508AAK and 11506AAK). Additionally, to compare the gestational age at delivery of cases completed using the new generation fetoscopes (11508AAK and 11506AAK) with that of matched historical control group completed prior to the introduction of 11508AAK and 11506AAK fetoscopes.

 

Participation eligibility

Participant eligibility includes age, gender, type and stage of disease, and previous treatments or health concerns. Guidelines differ from study to study, and identify who can or cannot participate. There is no guarantee that every individual who qualifies and wants to participate in a trial will be enrolled. Contact the study team to discuss study eligibility and potential participation.

Inclusion Criteria:

  • Patient is a pregnant woman 18 and older.
  • The mother must be healthy enough to have surgery.
  • The mother must be scheduled for surgery.
  • Patient provides signed informed consent that details the maternal and fetal risks involved with the procedure.

Exclusion Criteria:

  • Age < 18 years.
  • Contraindication to abdominal surgery, fetoscopic surgery, or general anesthesia.
  • Preterm labor, preeclampsia, or uterine anomaly (e.g., large fibroid tumor) in the index pregnancy.
  • Fetal aneuploidy, any significant pathogenic or likely significant pathogenic findings on Karyotype or Microarray (if available, but not required), other major fetal anomalies that impacts significantly the fetal/neonatal survival.

Note: Other protocol defined Inclusion/Exclusion Criteria may apply.

Eligibility last updated 2/1/24. Questions regarding updates should be directed to the study team contact.

Participating Mayo Clinic locations

Study statuses change often. Please contact the study team for the most up-to-date information regarding possible participation.

Mayo Clinic Location Status Contact

Rochester, Minn.

Mayo Clinic principal investigator

Mauro Schenone, M.D.

Open for enrollment

Contact information:

Mauro Schenone M.D.

(507) 284-0210

Schenone.Mauro@mayo.edu

More information

Publications

Publications are currently not available
.
CLS-20577079

Mayo Clinic Footer